Another full-regimen HIV pill enters the market: Triumeq

August 22, 2014 - Project Inform.

Convenient options for treating HIV infection got a boost today as the new all-in-one pill called Triumeq was approved by the FDA. Triumeq is a full HIV regimen made up of the three drugs dolutegravir (Tivicay), abacavir (Ziagen) and lamivudine (Epivir). Dolutegravir is an integrase inhibitor while the other two drugs are NRTIs, also available as Epzicom. Four full-regimen pills are now available as HIV treatment: Triumeq, Stribild, Complera and Atripla.

This is the first all-in-one HIV pill approved by the FDA without Truvada (tenofovir/emtricitabine), which makes it a new choice for those with impaired kidney function. Continue reading…

 

like0

Do you get our newsletter?

admin's picture

Sign up for our monthly Newsletter and get the latest info in you in box.

seventh name

Get information on several cancers that are common in HIV+ people: Kaposi's sarcoma, lymphoma, and cervical, liver, anal, and lung cancers.

Diarrhea is one of the most common problems for HIV+ people. Learn how it affects your body and what you can do to prevent and treat it.

Talking with children about HIV can be tough but important. Get some tips on how to share age appropriate information about HIV with kids.

admin's picture

Join our community

Connect to our support community and share experiences with other women living with HIV.

Join now >

admin's picture

You Can Help!

Together, we can change the course of the HIV epidemic…one woman at a time!

Please donate now!>